- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.7: 2 residues within 4Å:- Chain A: N.431, E.566
No protein-ligand interaction detected (PLIP)NAG.8: 2 residues within 4Å:- Chain A: Q.455, N.464
No protein-ligand interaction detected (PLIP)NAG.9: 1 residues within 4Å:- Chain A: N.1075
No protein-ligand interaction detected (PLIP)NAG.10: 2 residues within 4Å:- Chain A: N.506, Q.515
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.506
NAG.16: 2 residues within 4Å:- Chain B: N.431, E.566
No protein-ligand interaction detected (PLIP)NAG.17: 2 residues within 4Å:- Chain B: Q.455, N.464
No protein-ligand interaction detected (PLIP)NAG.18: 1 residues within 4Å:- Chain B: N.1075
No protein-ligand interaction detected (PLIP)NAG.19: 2 residues within 4Å:- Chain B: N.506, Q.515
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.506
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.11: 5 residues within 4Å:- Chain A: L.370, T.373, L.633, L.677, L.699
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.370, A:L.633, A:L.677, A:L.699
CLR.12: 5 residues within 4Å:- Chain A: F.1155, L.1158, W.1159, L.1245, L.1248
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.1155, A:L.1158, A:W.1159, A:W.1159, A:L.1245
CLR.20: 5 residues within 4Å:- Chain B: L.370, T.373, L.633, L.677, L.699
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:L.370, B:L.633, B:L.677, B:L.699
CLR.21: 5 residues within 4Å:- Chain B: F.1155, L.1158, W.1159, L.1245, L.1248
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:F.1155, B:L.1158, B:W.1159, B:W.1159, B:L.1245
- 2 x VIV: (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL(Non-covalent)
VIV.13: 16 residues within 4Å:- Chain A: L.382, W.383, F.404, T.407, Q.409, L.621, I.625, Q.873, Y.886, L.890, F.894, I.1097, T.1098, F.1101, Y.1102, L.1234
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:L.382, A:W.383, A:W.383, A:F.404, A:T.407, A:L.621, A:I.625, A:Q.873, A:L.890, A:F.894, A:I.1097, A:T.1098, A:F.1101, A:F.1101, A:L.1234
VIV.22: 16 residues within 4Å:- Chain B: L.382, W.383, F.404, T.407, Q.409, L.621, I.625, Q.873, Y.886, L.890, F.894, I.1097, T.1098, F.1101, Y.1102, L.1234
15 PLIP interactions:15 interactions with chain B- Hydrophobic interactions: B:L.382, B:W.383, B:W.383, B:F.404, B:T.407, B:L.621, B:I.625, B:Q.873, B:L.890, B:F.894, B:I.1097, B:T.1098, B:F.1101, B:F.1101, B:L.1234
- 2 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.14: 11 residues within 4Å:- Chain A: S.350, W.351, P.352, L.353, T.354, V.357, L.358, P.362
- Chain B: L.336, L.337, L.785
10 PLIP interactions:8 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:T.354, A:T.354, A:V.357, A:P.362, B:L.337, B:L.785
- Hydrogen bonds: A:L.353, A:T.354, A:T.354
- pi-Cation interactions: A:W.351
POV.15: 11 residues within 4Å:- Chain A: L.336, L.337, L.785
- Chain B: S.350, W.351, P.352, L.353, T.354, V.357, L.358, P.362
10 PLIP interactions:8 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:T.354, B:T.354, B:V.357, B:P.362, A:L.337, A:L.785
- Hydrogen bonds: B:L.353, B:T.354, B:T.354
- pi-Cation interactions: B:W.351
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, T. et al., Structures of dimeric human NPC1L1 provide insight into mechanisms for cholesterol absorption. Sci Adv (2021)
- Release Date
- 2021-09-01
- Peptides
- Isoform 2 of NPC1-like intracellular cholesterol transporter 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 2 x VIV: (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL(Non-covalent)
- 2 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, T. et al., Structures of dimeric human NPC1L1 provide insight into mechanisms for cholesterol absorption. Sci Adv (2021)
- Release Date
- 2021-09-01
- Peptides
- Isoform 2 of NPC1-like intracellular cholesterol transporter 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.